Research suggests that the nerve injury itself is to blame. Itch-sensing nerves, much like pain-sensing ones, can go haywire ...
Patients treated with 0.05% urcosimod demonstrated directionally favorable improvements in nerve fiber count and fiber length ...
TipRanks on MSN
OKYO Pharma reports positive phase 2 results for Urcosimod in neuropathic corneal pain
The latest announcement is out from OKYO Pharma Limited Sponsored ADR ( ($OKYO) ). On December 11, 2025, OKYO Pharma Limited ...
Shares of Okyo Pharma were higher Thursday after the company reported favorable nerve-restoration data for its drug that treats neuropathic corneal pain. Shares climbed 15% to $2.32 and are up twofold ...
Udupi: After six years of sustained research and clinical validation, the laser shoe, a novel, non-invasive therapy device for people living with type.
I've developed a yellow tongue. My oral hygiene has always been good, but my GP says it could be because I sleep on my back.
Researchers investigating the prevalence of vitamin D deficiency and insufficiency in individuals with chronic spinal cord injury assessed participants’ vitamin D levels using high-performance liquid ...
Brent Saunders returned to Bausch + Lomb in 2023 to help address unmet needs in eye care, focusing on innovation and ...
POTS (Postural Orthostatic Tachycardia Syndrome) represents a mechanical failure of blood flow, distinct from standard heart ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results